Kenji Okuma

A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model

Misato Ito, Shunji Yamazaki, Kaoru Yamagami et al. · Journal of Pharmacological Sciences · 2016 · 93 citations · Full text

Medicine, Immunology, Pharmacology +17

Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis

Chiyomi Sasaki, Tomoko Hiraishi, Takuma Oku et al. · PLoS ONE · 2019 · 77 citations · Full text

Life Sciences, Biochemistry, Mass Spectrometric Analysis +16

Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis

Takeshi Iwasaki, Ryu Watanabe, Hiromu Ito et al. · Frontiers in Immunology · 2022 · 40 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer

Tadashi Watabe, Kazuko Kaneda‐Nakashima, Kazuhiro Ooe et al. · Annals of Nuclear Medicine · 2021 · 37 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17

AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts

Koji Nakamura, Masamichi Inami, Hiroki Morio et al. · European Journal of Pharmacology · 2016 · 14 citations

Medicine, Immunology, Pharmacology +16